Analysis Group Launches Experts’ Table Series with a Discussion on AI and Competition in Europe

Mr. Feige specializes in the areas of finance, securities, and financial markets. He has worked on and managed a range of securities and valuation projects in the UK and Europe. Mr. Feige has been appointed as expert in Dutch court to provide valuation and securities claims reports in support of Steinhoff’s global securities settlement, and gave evidence in the Dutch Enterprise Chamber regarding the valuation of Getir. He has also managed teams evaluating shareholder reliance and disclosure materiality and estimating counterfactual share prices in UK Financial Services and Markets Act (FSMA) Section 90A litigation matters. Mr. Feige has supported experts analyzing the volume of false and spam accounts on Twitter, Twitter’s information security infrastructure, Twitter’s data privacy and compliance with a US Federal Trade Commission (FTC) consent decree, and share price and valuation issues on behalf of Twitter in Twitter v. Musk in which Elon Musk eventually purchased Twitter at his initial offer price. In cases involving alleged market manipulation in the foreign exchange (FX) and IBOR markets, he has analyzed trade data and evaluated alleged manipulation strategies. Mr. Feige worked on USA v. Richard Usher, et al., and the Foreign Exchange Class Antitrust Litigation, analyzing FX trade and chat data, as well as competition issues; preparing experts for testimony at trial; and providing data analyses and consulting support to counsel throughout the projects. He has also worked on a range of international arbitration cases, including valuation, damages, and competition analyses. In addition, he has developed complex valuation models, including discounted cash flow models, and analyzed asset-backed securities, collateralized debt obligations, and other securitized products in support of expert testimony in a number of bankruptcy and damages matters. Mr. Feige has also worked on a number of international arbitrations valuing defaulted sovereign debt, expropriated oil fields, and retail operations. His work has been published in several industry journals.

Dr. Hariton specializes in the application of industrial organization and competition economics to merger control, antitrust and competition, state aid, and regulatory matters, including extensive work in large-scale merger investigations and competition litigation before the European Commission and national competition authorities. He previously served as an economist at the European Commission’s Directorate-General for Competition (DG COMP). Dr. Hariton has advised on more than 75 merger reviews, including those of Halliburton/Baker Hughes, Dow/DuPont, Bayer/Monsanto, and Salesforce/Slack by the US Department of Justice (DOJ), as well as antitrust cases involving Intel, Servier, and Glaxo Wellcome. His experience includes work on state aid, damages estimation, and regulatory proceedings, as well as work on Digital Services Act fee challenges and foreign subsidies regulation. Dr. Hariton also brings distinctive expertise as a forensic IT expert, having assisted in multiple inspections and investigations. He has published in journals including the Review of Industrial Organization, the Journal of Public Economic Theory, the Journal of Regulatory Economics, the Journal of the Japanese and International Economies, Revue Économique, and Recherches Économiques de Louvain, and has contributed to European Commission consultations and newsletters. Dr. Hariton previously served as an assistant professor at Toulouse Business School and as a research fellow at UCLouvain.

Mr. White is a consulting and testifying economist who specializes in applying microeconomics and sophisticated econometric modelling to complex litigation and merger-related questions, primarily in matters involving the health care, financial services, and technology industries. He has supported clients in various jurisdictions and industries in follow-on competition damages litigation, assessing overcharge, upstream and downstream pass-on, and volume effects. He has served as a testifying expert in the UK Upper Tribunal (Lands Chamber), the UK Competition Appeal Tribunal, and the Amsterdam District Court on competition cases.

Mr. White has supported high-profile companies with complex merger reviews across multiple jurisdictions, including in the Veolia/Suez, LVMH/Tiffany, Sika/MBCC, and Eutelsat/OneWeb mergers. He has also provided evidence to the UK’s Competition and Markets Authority (CMA) and the European Commission, including on behalf of clients involved in cartel investigations, abuse of dominance investigations, and mergers. Mr. White has also provided support to European financial and competition regulators in coordinated conduct investigations.

Mr. White has extensive experience addressing competition and intellectual property (IP) issues in matters related to cutting-edge pharmaceutical products and FRAND licensing questions. As part of this work, he has supported a number of scientific and technical experts in front of courts and regulatory bodies. He also regularly supports pharmaceutical clients on competition issues around market access, pricing, denigration, and competition from generic manufacturers.

Mr. White has worked in a number of jurisdictions, including the UK, the European Union, Switzerland, Australia, New Zealand, South Africa, Canada, Japan, Korea, the Netherlands, Belgium, and the US. His writing has been published in an array of journals, including the Journal of European Competition Law & Practice, the Competition Law Journal, and the Journal of Antitrust Enforcement, and he regularly speaks at international competition law and policy conferences.